EP
ABBV icon

Edgestream Partners’s AbbVie ABBV Stock Holding History

Edgestream Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.61M Sell
7,402
-58,230
-89% -$12.9M 0.05% 546
2025
Q4 		$15M Buy
65,632
+56,150
+592% +$12.8M 0.42% 13
2025
Q3 		$2.2M Sell
9,482
-57,476
-86% -$11.7M 0.06% 506
2025
Q2 		$12.4M Buy
+66,958
New +$12.4M 0.35% 34
2025
Q1 		– Sell
-13,722
Closed -$2.44M – 816
2024
Q4 		$2.44M Sell
13,722
-34,744
-72% -$6.39M 0.1% 354
2024
Q3 		$9.57M Buy
+48,466
New +$9.05M 0.42% 10
2024
Q2 		– Sell
-29,001
Closed -$5.28M – 818
2024
Q1 		$5.28M Sell
29,001
-6,273
-18% -$1.08M 0.26% 94
2023
Q4 		$5.47M Buy
35,274
+30,718
+674% +$4.48M 0.39% 16
2023
Q3 		$679K Buy
+4,556
New +$669K 0.05% 514

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Edgestream Partners's ABBV Position: Q1 2026 in Review

Edgestream Partners reduced its AbbVie (ABBV) stake by 89% in Q1 2026, selling an estimated $12.9M and leaving 7,402 shares worth $1.61M. The position accounts for 0.05% of the portfolio, ranked #546.

Edgestream Partners first reported a position in ABBV in Q3 2023 and has held it in 9 quarters since. The position peaked at $15M in Q4 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Edgestream Partners held 7,402 shares of AbbVie worth $1.61M as of Q1 2026.
  • Edgestream Partners sold 58,230 AbbVie shares in Q1 2026, an estimated $12.9M.
  • AbbVie made up 0.05% of Edgestream Partners's portfolio in Q1 2026, its #546 holding.
  • Edgestream Partners first reported a position in AbbVie in Q3 2023 and has held it in 9 quarters since.
  • Edgestream Partners's AbbVie position peaked at $15M in Q4 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Edgestream Partners's 13F filing for Q1 2026, filed 18 May 2026.